Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-06

Clinical Trial Update: Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether bromfenac affects macular thickness after phacoemulsification cataract surgery, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BROMFENAC (Bromfenac)

Snippet

Sponsor: Inas Abd | Conditions: Cataract, Cystoid Macular Edema After Phacoemulsification | Phase 4 | Status: COMPLETED | Results posted: 2025-05-06